NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

除蟲藥的全球市場:各醫藥品分類、給藥途徑、標的病原體、用途、流通管道 - 至2025年的預測,COVID-19累積的影響

Anthelmintic Drugs Market Research Report by Drug Class, by Route of Administration, by Target Pathogen, by Application, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 973200
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
除蟲藥的全球市場:各醫藥品分類、給藥途徑、標的病原體、用途、流通管道 - 至2025年的預測,COVID-19累積的影響 Anthelmintic Drugs Market Research Report by Drug Class, by Route of Administration, by Target Pathogen, by Application, by Distribution Channel, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 189 Pages
簡介

全球除蟲藥的市場規模,2019年是17億2,567萬美金。該市場,預計至2025年期間以13.62%的年複合成長率成長,達到37億1,391萬美元。

本報告提供全球除蟲藥市場的相關調查,市場機會和課題,成長及阻礙因素,COVID-19的影響,各標的病原體、給藥途徑、藥物類別、用途、流通管道、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

第2章 調查手法

  • 調查流程
  • 調查的實行
  • 調查成果

第3章 摘要整理

  • 簡介
  • 市場預測
  • 標的病原體
  • 給藥途徑
  • 藥物類別
  • 用途
  • 流通管道
  • 地區
  • 競爭

第4章 市場概要

  • 簡介

第5章 市場動態

  • 簡介
  • 成長要素
    • 全球寵物飼養的增加
    • 動物的醫療保健與健康的支出增加
  • 阻礙因素
    • 寄生蠕蟲的藥物抗性上升
  • 市場機會
    • 為了促進研究活動與贊助商合作
    • 在世界中增加的獸醫醫療保健服務中心
  • 課題
    • 綿羊生產國的除蟲藥抗性

第6章 市場洞察

  • 波特的五力分析
  • COVID-19累積的影響
  • 客戶的客製化

第7章 市場分析:各類藥物

  • 簡介
  • 苯並咪唑酮
  • Piperazine

第8章 市場分析:各給藥途徑

  • 簡介
  • 注射
  • 口服

第9章 市場分析:各標的病原體

  • 簡介
  • 十二指腸鉤蟲
  • 人蛔蟲
  • 蟯蟲
  • 鞭蟲

第10章 市場分析:各用途

  • 簡介
  • 動物
    • 腸胃感染疾病
    • 神經囊蟲症

第11章 市場分析:各流通管道

  • 簡介
  • 醫院藥局
  • 線上藥局
  • 零售藥局
  • 獸醫醫院、診所
  • 動物醫藥局

第12章 南北美洲市場

  • 簡介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第13章 亞太地區市場

  • 簡介
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第14章 歐洲、中東、非洲市場

  • 簡介
  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第15章 競爭情形

  • FPNV Positioning Matrix
  • 市場排行榜分析
  • 市場佔有率分析
  • 競爭模式
    • 合併和收購
    • 協定,合作,及聯盟
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 獲獎,獎勵,擴大

第16章 企業的實用性簡介

  • Amneal Pharmaceuticals Inc.
  • Anikem Laboratories
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc.
  • Merck & Co. Inc
  • Novartis AG
  • Sankur Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd
  • Swiss Pharma Pvt. Ltd
  • Zoetis, Inc.

第17章 附錄

  • 討論指南

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-FB6C9E792F95

The Global Anthelmintic Drugs Market size was estimated at USD 2,648.36 Million in 2020 and expected to reach USD 2,846.90 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.83% to reach USD 4,164.28 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Anthelmintic Drugs to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Drug Class, the Anthelmintic Drugs Market was studied across Benzimidazoles and Piperazine.

Based on Route of Administration, the Anthelmintic Drugs Market was studied across Injectable and Oral.

Based on Target Pathogen, the Anthelmintic Drugs Market was studied across Ancylostoma Duodenale, Ascaris Lumbricoides, Enterobius Vermicularis, and Trichuris Trichiura.

Based on Application, the Anthelmintic Drugs Market was studied across Animal and Human. The Human is further studied across Gastrointestinal Infections and Parenchymal Neurocysticercosis.

Based on Distribution Channel, the Anthelmintic Drugs Market was studied across Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Veterinary Hospitals & Clinics, and Veterinary Pharmacies.

Based on Geography, the Anthelmintic Drugs Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anthelmintic Drugs Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Anthelmintic Drugs Market, including Alkem Laboratories Limited, Amneal Pharmaceuticals Inc., Anikem Laboratories, Arbor Pharmaceuticals Inc, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cadila Healthcare Limited, Cipla Inc., GlaxoSmithKline PLC, Ipca Laboratories Ltd, Janssen Pharmaceuticals, Inc., Johnson & Johnson Services, Inc., LGM Pharma, Lupin Limited, Mankind Pharma, Merck & Co. Inc, Novartis AG, Pfizer Inc., Sankur Pharmaceuticals Pvt. Ltd, Sanofi SA, Sun Pharmaceutical Industries Ltd, Swiss Pharma Pvt. Ltd, Virbac, and Zoetis, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Anthelmintic Drugs Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anthelmintic Drugs Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anthelmintic Drugs Market?
  • 4. What is the competitive strategic window for opportunities in the Global Anthelmintic Drugs Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Anthelmintic Drugs Market?
  • 6. What is the market share of the leading vendors in the Global Anthelmintic Drugs Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Anthelmintic Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Target Pathogen Outlook
  • 3.4. Route of Administration Outlook
  • 3.5. Drug Class Outlook
  • 3.6. Application Outlook
  • 3.7. Distribution Channel Outlook
  • 3.8. Geography Outlook
  • 3.9. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing pet adoption across the world
      • 5.1.1.2. Increasing spending for animal healthcare and wellness
    • 5.1.2. Restraints
      • 5.1.2.1. Rise in drug resistance by parasitic helminths
    • 5.1.3. Opportunities
      • 5.1.3.1. Sponsored collaboration to fuel research activities
      • 5.1.3.2. Increasing veterinary healthcare services centers across the world
    • 5.1.4. Challenges
      • 5.1.4.1. Anthelmintic resistance in sheep producing countries
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Anthelmintic Drugs Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Benzimidazoles
  • 6.3. Piperazine

7. Anthelmintic Drugs Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral

8. Anthelmintic Drugs Market, by Target Pathogen

  • 8.1. Introduction
  • 8.2. Ancylostoma Duodenale
  • 8.3. Ascaris Lumbricoides
  • 8.4. Enterobius Vermicularis
  • 8.5. Trichuris Trichiura

9. Anthelmintic Drugs Market, by Application

  • 9.1. Introduction
  • 9.2. Animal
  • 9.3. Human
    • 9.3.1. Gastrointestinal Infections
    • 9.3.2. Parenchymal Neurocysticercosis

10. Anthelmintic Drugs Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies
  • 10.5. Veterinary Hospitals & Clinics
  • 10.6. Veterinary Pharmacies

11. Americas Anthelmintic Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States
    • 11.6.1. California
    • 11.6.2. Florida
    • 11.6.3. Illinois
    • 11.6.4. New York
    • 11.6.5. Ohio
    • 11.6.6. Pennsylvania
    • 11.6.7. Texas

12. Asia-Pacific Anthelmintic Drugs Market

  • 12.1. Introduction
  • 12.2. China
  • 12.3. India
  • 12.4. Indonesia
  • 12.5. Japan
  • 12.6. Malaysia
  • 12.7. Philippines
  • 12.8. South Korea
  • 12.9. Thailand

13. Europe, Middle East & Africa Anthelmintic Drugs Market

  • 13.1. Introduction
  • 13.2. France
  • 13.3. Germany
  • 13.4. Italy
  • 13.5. Netherlands
  • 13.6. Qatar
  • 13.7. Russia
  • 13.8. Saudi Arabia
  • 13.9. South Africa
  • 13.10. Spain
  • 13.11. United Arab Emirates
  • 13.12. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
    • 14.1.1. Quadrants
    • 14.1.2. Business Strategy
    • 14.1.3. Product Satisfaction
  • 14.2. Market Ranking Analysis
  • 14.3. Market Share Analysis, By Quadrant
  • 14.4. Market Share Analysis, By Company
  • 14.5. Competitive Scenario
    • 14.5.1. Merger & Acquisition
    • 14.5.2. Agreement, Collaboration, & Partnership
    • 14.5.3. New Product Launch & Enhancement
    • 14.5.4. Investment & Funding
    • 14.5.5. Award, Recognition, & Expansion

15. Company Usability Profiles

  • 15.1. Alkem Laboratories Limited
  • 15.2. Amneal Pharmaceuticals Inc.
  • 15.3. Anikem Laboratories
  • 15.4. Arbor Pharmaceuticals Inc
  • 15.5. AstraZeneca PLC
  • 15.6. Boehringer Ingelheim International GmbH
  • 15.7. Cadila Healthcare Limited
  • 15.8. Cipla Inc.
  • 15.9. GlaxoSmithKline PLC
  • 15.10. Ipca Laboratories Ltd
  • 15.11. Janssen Pharmaceuticals, Inc.
  • 15.12. Johnson & Johnson Services, Inc.
  • 15.13. LGM Pharma
  • 15.14. Lupin Limited
  • 15.15. Mankind Pharma
  • 15.16. Merck & Co. Inc
  • 15.17. Novartis AG
  • 15.18. Pfizer Inc.
  • 15.19. Sankur Pharmaceuticals Pvt. Ltd
  • 15.20. Sanofi SA
  • 15.21. Sun Pharmaceutical Industries Ltd
  • 15.22. Swiss Pharma Pvt. Ltd
  • 15.23. Virbac
  • 15.24. Zoetis, Inc.

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing
  • 16.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 8. GLOBAL ANTHELMINTIC DRUGS MARKET: MARKET DYNAMICS
  • FIGURE 9. GLOBAL ANTHELMINTIC DRUGS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 10. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (%)
  • FIGURE 11. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2026
  • FIGURE 13. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY PIPERAZINE, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY PIPERAZINE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2026
  • FIGURE 20. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY INJECTABLE, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ORAL, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2020 VS 2026 (%)
  • FIGURE 25. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2026
  • FIGURE 27. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANCYLOSTOMA DUODENALE, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANCYLOSTOMA DUODENALE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ASCARIS LUMBRICOIDES, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ASCARIS LUMBRICOIDES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ENTEROBIUS VERMICULARIS, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ENTEROBIUS VERMICULARIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TRICHURIS TRICHIURA, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TRICHURIS TRICHIURA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 36. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 38. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL, 2018-2026 (USD MILLION)
  • FIGURE 39. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 40. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, 2018-2026 (USD MILLION)
  • FIGURE 41. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 42. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2026 (USD MILLION)
  • FIGURE 43. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 44. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY PARENCHYMAL NEUROCYSTICERCOSIS, 2018-2026 (USD MILLION)
  • FIGURE 45. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY PARENCHYMAL NEUROCYSTICERCOSIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 46. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (%)
  • FIGURE 47. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2026
  • FIGURE 49. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 50. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 51. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 52. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 53. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 54. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 55. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, 2018-2026 (USD MILLION)
  • FIGURE 56. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 57. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, 2018-2026 (USD MILLION)
  • FIGURE 58. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 60. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 61. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 62. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. CALIFORNIA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. FLORIDA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. ILLINOIS ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. NEW YORK ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. OHIO ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. PENNSYLVANIA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. TEXAS ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 75. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 76. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 77. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 78. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 79. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 80. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 81. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 82. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 83. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 84. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 85. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 86. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 87. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 88. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 89. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 90. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 91. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 92. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 93. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 94. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 95. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 96. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 97. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 98. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 99. GLOBAL ANTHELMINTIC DRUGS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 100. GLOBAL ANTHELMINTIC DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 101. GLOBAL ANTHELMINTIC DRUGS MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 102. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ANTHELMINTIC DRUGS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ANTHELMINTIC DRUGS MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY BENZIMIDAZOLES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY PIPERAZINE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY INJECTABLE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ORAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANCYLOSTOMA DUODENALE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ASCARIS LUMBRICOIDES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ENTEROBIUS VERMICULARIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY TRICHURIS TRICHIURA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ANIMAL, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY HUMAN, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY PARENCHYMAL NEUROCYSTICERCOSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY HOSPITALS & CLINICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. GLOBAL ANTHELMINTIC DRUGS MARKET SIZE, BY VETERINARY PHARMACIES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. AMERICAS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. ARGENTINA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. BRAZIL ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. CANADA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. MEXICO ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. UNITED STATES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. CALIFORNIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. CALIFORNIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. CALIFORNIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. CALIFORNIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. CALIFORNIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. FLORIDA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. FLORIDA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. FLORIDA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. FLORIDA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. FLORIDA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. ILLINOIS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. ILLINOIS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. ILLINOIS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. ILLINOIS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. ILLINOIS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. NEW YORK ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. NEW YORK ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. NEW YORK ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. NEW YORK ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. NEW YORK ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. OHIO ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. OHIO ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. OHIO ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. OHIO ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. OHIO ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. PENNSYLVANIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. PENNSYLVANIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. PENNSYLVANIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. PENNSYLVANIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. PENNSYLVANIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. TEXAS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. TEXAS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. TEXAS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. TEXAS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. TEXAS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ASIA-PACIFIC ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. CHINA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. INDIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. INDONESIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. JAPAN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. MALAYSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 123. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 124. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 125. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 126. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 127. PHILIPPINES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 128. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 129. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 130. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 131. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 132. SOUTH KOREA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 133. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 134. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 135. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 136. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 137. THAILAND ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 144. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 145. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 146. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 147. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 148. FRANCE ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 149. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 150. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 151. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 152. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 153. GERMANY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 154. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 155. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 156. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 157. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 158. ITALY ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 159. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 160. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 161. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 162. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 163. NETHERLANDS ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 164. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 165. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 166. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 167. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 168. QATAR ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 169. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 170. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 171. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 172. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 173. RUSSIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 174. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 175. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 176. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 177. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 178. SAUDI ARABIA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 179. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 180. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 181. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 182. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 183. SOUTH AFRICA ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 184. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 185. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 186. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 187. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 188. SPAIN ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 193. UNITED ARAB EMIRATES ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 194. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY TARGET PATHOGEN, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 195. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 196. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 197. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 198. UNITED KINGDOM ANTHELMINTIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 199. GLOBAL ANTHELMINTIC DRUGS MARKET: SCORES
  • TABLE 200. GLOBAL ANTHELMINTIC DRUGS MARKET: BUSINESS STRATEGY
  • TABLE 201. GLOBAL ANTHELMINTIC DRUGS MARKET: PRODUCT SATISFACTION
  • TABLE 202. GLOBAL ANTHELMINTIC DRUGS MARKET: RANKING
  • TABLE 203. GLOBAL ANTHELMINTIC DRUGS MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 204. GLOBAL ANTHELMINTIC DRUGS MARKET: SHARE, BY COMPANY, 2020
  • TABLE 205. GLOBAL ANTHELMINTIC DRUGS MARKET: MERGER & ACQUISITION
  • TABLE 206. GLOBAL ANTHELMINTIC DRUGS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 207. GLOBAL ANTHELMINTIC DRUGS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 208. GLOBAL ANTHELMINTIC DRUGS MARKET: INVESTMENT & FUNDING
  • TABLE 209. GLOBAL ANTHELMINTIC DRUGS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 210. GLOBAL ANTHELMINTIC DRUGS MARKET: LICENSE & PRICING
  • TABLE 211. GLOBAL ANTHELMINTIC DRUGS MARKET: CONTACT DETAILS